1. Home
  2. CAPL vs ZVRA Comparison

CAPL vs ZVRA Comparison

Compare CAPL & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CrossAmerica Partners

CAPL

CrossAmerica Partners

HOLD

Current Price

$22.02

Market Cap

858.5M

Sector

Energy

ML Signal

HOLD

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

HOLD

Current Price

$12.90

Market Cap

741.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAPL
ZVRA
Founded
1992
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
858.5M
741.9M
IPO Year
2012
2015

Fundamental Metrics

Financial Performance
Metric
CAPL
ZVRA
Price
$22.02
$12.90
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$23.00
AVG Volume (30 Days)
44.1K
2.1M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
9.96%
N/A
EPS Growth
96.15
159.21
EPS
0.26
0.60
Revenue
$1,869,806,000.00
$106,470,000.00
Revenue This Year
N/A
$37.27
Revenue Next Year
$2.80
$53.42
P/E Ratio
$83.54
$21.62
Revenue Growth
N/A
350.91
52 Week Low
$19.61
$7.16
52 Week High
$23.34
$14.27

Technical Indicators

Market Signals
Indicator
CAPL
ZVRA
Relative Strength Index (RSI) 49.89 61.82
Support Level $21.53 $8.26
Resistance Level $23.01 $14.27
Average True Range (ATR) 0.56 0.76
MACD -0.08 0.07
Stochastic Oscillator 49.83 65.01

Price Performance

Historical Comparison
CAPL
ZVRA

About CAPL CrossAmerica Partners

CrossAmerica Partners LP is engaged in the wholesale distribution of motor fuel and the ownership and leasing of real estate used in the retail distribution of motor fuel. The company operates through two business segments, namely Wholesale and Retail. The Wholesale segment is a key revenue driver and includes the wholesale distribution of motor fuel to lessee dealers, independent dealers, commission agents, DMS, Circle K, and through company-operated retail sites. The Retail segment includes the sale of convenience merchandise items, the retail sale of motor fuel at company-operated retail sites, and the retail sale of motor fuel at retail sites operated by commission agents.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

Share on Social Networks: